News
ADMA Biologics Highlights Launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA...
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the launch of COVID-19 ImmunoRank Neutralization...
News
UNICEF to lead procurement and supply of COVID-19 vaccines...
UNICEF is leading efforts to procure and supply COVID-19 vaccines in what could possibly be the world’s largest and fastest ever procurement and supply of...
News
Mesoblast Limited receives ethics approval to treat COVID-19 patients...
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has received ethics approval to include Australian hospitals in thePhase 3...
News
Delivery of COVID-19 vaccine: DHL study shows how public...
With first emergency use authorizations for COVID-19 vaccines expected to be effective in the last quarter of 2020, logistics providers are challenged to rapidly establish...
Clinical Trials
Bharat Biotech gets approval to conduct phase 2 trials...
Hyderabad-based Bharat Biotech has received approval to conduct phase II trials of its COVID-19 vaccine Covaxin from September 7.
The Directorate General of Health Service said...
Clinical Trials
Early trials find Russia’s Sputnik V safe, volunteers develop...
Much buzz was created around the world when Russia claimed to have approved the first COVID-19 vaccine around the world, for public use. Experts and...
News
CureVac to Receive 252million Euros to Support COVID-19 Vax...
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) in clinical trials, has received notification from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.